We live in a world where every day we come across a new invention. There are so many out-of-box inventions and here we add one more to the list. Recently, Royal Philips declared the global rollout of its next-generation image-guided therapy interface, Azurion, which is able of performing a large variety of routine, minimum invasive, catheter-dependent processes in the hybrid operating room or interventional lab. The new imaging interface is developed by redesigning Philip’s ConnectOS. The new technique presents a new user platform aimed at prioritizing user-friendliness and raise control from various sites in the interventional set.
It is also claimed to be competent of instantaneous processing of information from several sources, including interventional devices, imaging systems, patient health records, and navigation tools. It incorporates diverse Philips-branded navigation and planning software, that are, for interventional neuroradiology (AneurysmFlow), interventional cardiology (EchoNavigator), vascular surgery (VesselNavigator), and interventional oncology (EmboGuide). Azurion is also provided with procedure cards that permit clinicians to program user preferences and routine tasks beforehand, aid in reducing preparation blunders and also decrease procedure and preparation duration. A tablet with tailored platforms can be utilized to handle the system that presents almost 1,000 novel elements functioning together to provide a high-quality image at ultra-low X-ray dose. In additional, C-arm of Azurion is made to rotate and pan such that fluoroscopy is not needed.
Philip’s Business Leader of Image Guided Therapy, Bert van Meurs, said, “Several of Philips engineers, designers, developers, and many of our clinical collaborators around the globe have joined forces to wholly brighten up the heart of our collection. With the roll out of our new platform, Azurion, which has been developed to enhance lab performance & system integration, it will be possible for us to provide new solutions that hold our consumers in sustaining high-quality standards and patient care at a conventional price.”
Azurion will be soon accessible in single-plane as well as biplane configurations. At present, only the single-plane configuration is accessible, whereas the biplane version will be available shortly this year.
We hope this new device helps the professionals to better diagnose the disease and help patients to improve their quality of life.